Biovatas - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | - | 613,548 | 1,638,244 | 1,825,300 | 3,077,391 | 3,048,106 | 4,517,987 | 4,882,207 |
| Profit before tax | - | 183,849 | 156,498 | -209,712 | -154,465 | 27,434 | 915,612 | 756,191 |
| Net profit | -1,445 | 157,312 | 133,023 | -209,712 | -154,465 | 26,489 | 932,653 | 691,773 |
| Equity | -4,040 | 510,376 | 643,399 | 433,688 | 279,222 | 303,367 | 1,236,020 | 3,196,186 |
| Liabilities | 7,844 | 3,068,777 | 2,612,652 | 2,714,244 | 3,179,345 | 8,346,002 | 7,352,186 | 3,407,944 |
| Non-current assets | 0 | 3,134,537 | 2,850,531 | 2,609,875 | 2,324,225 | 13,109,813 | 13,258,558 | 11,490,890 |
| Current assets | 216 | 441,731 | 403,187 | 535,307 | 1,198,393 | 1,075,772 | 1,249,306 | 646,754 |
| Total assets | 216 | 3,576,268 | 3,253,718 | 3,145,182 | 3,522,618 | 14,185,585 | 14,507,864 | 12,137,644 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 135,241 | 308,722 | 522,673 |
| Social insurance contributions | - | - | - | - | - | 39,350 | 62,609 | 69,442 |
|
Financial indicators
|
||||||||
| Revenue change y/y | - | - | +167.0% | +11.4% | +68.6% | -1.0% | +48.2% | +8.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -669.0% | 4.4% | 4.1% | -6.7% | -4.4% | 0.2% | 6.4% | 5.7% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | 30.8% | 20.7% | -48.4% | -55.3% | 8.7% | 75.5% | 21.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | 25.6% | 8.1% | -11.5% | -5.0% | 0.9% | 20.6% | 14.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | 30.0% | 9.6% | -11.5% | -5.0% | 0.9% | 20.3% | 15.5% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | 6.0 | 4.1 | 6.3 | 11.4 | 27.5 | 5.9 | 1.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | 306,774 | 322,280 | 365,060 | 615,478 | 609,621 | 637,836 | 610,276 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Biovatas - Social security debts
The company had no debts to Sodra
Biovatas - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-03-28 | 2025-04-25 | 0.67 |
| 2025-03-20 | 2025-03-24 | 0.67 |
| 2025-02-28 | 2025-03-12 | 0.67 |
| 2025-02-20 | 2025-02-24 | 0.67 |
| 2025-02-02 | 2025-02-18 | 2.08 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Biovatas, UAB (code 303225457) is a Private Limited Liability Company operating in electricity production from renewable sources. In 2025, the company generated revenue of €4.88M, up 8.1% year on year and 60.2% over two years, showing a clear expansion from €3.05M in 2023 and €4.52M in 2024. Net profit in 2025 was €691.8K, below the 2024 level of €932.7K but still well above the €26.5K reported in 2023. The 2025 profit margin was 14.2%, compared with 20.6% in 2024 and 0.9% in 2023. At the end of 2025, total assets were €12.14M, of which €11.49M were long-term assets and €646.8K short-term assets. Equity increased to €3.20M, while liabilities fell to €3.41M from €7.35M in 2024. The company’s equity ratio was 26.3% and debt-to-equity 1.07. Return on equity was 21.6% and return on assets 5.7%. Revenue per employee reached €610.3K, and profit per employee €86.5K, indicating strong operating productivity.